CLDN1 and breast cancer: While one study reported that the activation of CLDN-1 was repressed by the binding of E-cadherin to CLDN-1 promoter [77], knockdown of CLDN-1 has been found to be associated with decreased cell migration and induction of EMT in breast cancer cells [76].